With more ADCs entering the clinic than ever before, it has never been more important to optimize clinical strategies to demonstrate differentiation and benefit oncology patients.

Attend this session to follow ADC clinical trends across development phases from early to late-stage, and contextualize evolving strategies to stand out from the crowd and maximize differentiation opportunity in crowded oncology indications.

Workshop highlights include:

• Breaking down the ADC clinical development trends in an increasingly busy oncology treatment landscape: How will ADCs fit into future patient therapy regiments?
• Evolving strategies to unlock clinical benefit across combination and sequencing approaches as more ADCs are approved, particularly into front-line patient therapies
• Finding the right patient for the right ADC: Evaluating when and how to implement patient cut-off criteria